Amarin CEO on Future of Heart Drug Vascepa

The transcript discusses the positive results of a new drug, addressing concerns about its comparison to mineral oil. It highlights the drug's efficacy in reducing heart attack, stroke, and death rates. The company plans to expand its sales force and explore global partnerships. The discussion includes patient profiles, study design, and the importance of a holistic approach to health. The drug's affordability and strong reimbursement are emphasized as key factors for its success.

What is the significance of the study design agreed upon with the FDA?

What role does diet and exercise play in the context of the drug's effectiveness?

How does the company plan to expand its reach to patients in the United States and beyond?